Key result
Targeted pharmacist intervention improved the rate of follow-up ECG monitoring from 47.8% to 100% in pediatric patients prescribed 3 or more QTc interval-prolonging medications.
Why the study?
Does a targeted pharmacist intervention improve the rate of ECG monitoring in pediatric patients prescribed multiple QTc interval-prolonging medications?
Cohort (n=130)
No
Does a targeted pharmacist intervention improve the rate of ECG monitoring in pediatric patients prescribed multiple QTc interval-prolonging medications?
Absolute Event Rate: 100% vs 47.8%
p-value: p=0.0009
A targeted pharmacist intervention significantly improved the rate of follow-up ECG monitoring for pediatric patients prescribed multiple QTc-prolonging medications, highlighting the value of dedicated pharmacy services in medication safety.
May improve ECG monitoring adherence in high-risk pediatric patients; leaves open effects on arrhythmic outcomes.
OBJECTIVES: To determine whether dedicated pharmacy services improve the rate of electrocardiogram (ECG) monitoring in patients at risk for medication-induced QTc interval prolongation. In addition, determine how pediatric institutions currently monitor patients at risk for medication-induced QTc interval prolongation. METHODS: A pharmacist-driven monitoring protocol to detect medication-induced QTc interval prolongation was developed using published literature. If patients were prescribed 3 or more medications known to prolong the QTc interval, they were recommended to have a baseline ECG to assess the QTc interval. If 3 or more QTc interval-prolonging medications were administered for 5 or more days, a follow-up ECG was recommended. Patients prescribed medications known to prolong the QTc interval were identified. Prior to pharmacist intervention, electronic medical records were reviewed to determine if baseline and follow-up ECGs were obtained in patients meeting criteria for monitoring. A dedicated pharmacist then prospectively reviewed charts and recommended monitoring. The rate of monitoring during the intervention and baseline period was compared. To determine current practice at pediatric institutions, a survey was distributed to pharmacists. RESULTS: Pharmacist intervention improved the rate of ECG monitoring in patients at risk for medication-induced QTc interval prolongation from 47.8% to 100% (p = 0.0009). Of the 55 survey participants, 6 stated their institution had QTc interval monitoring procedures in place, 35 did not have any, and 3 had procedures in process. CONCLUSIONS: Targeted pharmacist intervention improved the rate of ECG monitoring in patients at risk for medication-induced prolonged QTc interval. Our research and survey data reveal that institutions could benefit from targeted pharmacist intervention to monitor patients for medication-induced QTc interval prolongation.
No takes yet. Share an insight, caveat, or question.
Hutchins et al. (2017) conducted a cohort in Risk for medication-induced QTc interval prolongation (n=130). Pharmacist-driven monitoring protocol vs. Historical practice (retrospective cohort) was evaluated on Rate of follow-up ECG monitoring in patients meeting criteria (p=0.0009). Targeted pharmacist intervention improved the rate of follow-up ECG monitoring from 47.8% to 100% in pediatric patients prescribed 3 or more QTc interval-prolonging medications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: